Equities

Privia Health Group Inc

PRVA:NSQ

Privia Health Group Inc

Actions
Health CareHealth Care Providers
  • Price (USD)22.58
  • Today's Change-0.22 / -0.96%
  • Shares traded813.63k
  • 1 Year change+3.63%
  • Beta0.8568
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy8
Outperform12
Hold2
Sell0
Strong Sell0

Share price forecast in USD

The 20 analysts offering 12 month price targets for Privia Health Group Inc have a median target of 26.00, with a high estimate of 37.00 and a low estimate of 21.00. The median estimate represents a 15.15% increase from the last price of 22.58.
High63.9%37.00
Med15.1%26.00
Low-7.0%21.00

Earnings history & estimates in USD

On Nov 07, 2024, Privia Health Group Inc reported 3rd quarter 2024 earnings of 0.03 per share. This result was in line with the consensus of the 15 analysts following the company and under-performed last year's 3rd quarter results by 40.00%.
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate-2.50%
Privia Health Group Inc reported annual 2023 earnings of 0.19 per share on Feb 27, 2024.
Average growth rate+95.63%
More ▼

Revenue history & estimates in USD

Privia Health Group Inc had 3rd quarter 2024 revenues of 739.90m. This bettered the 714.78m consensus of the 14 analysts covering the company. This was 12.29% above the prior year's 3rd quarter results.
Average growth rate+0.65%
Privia Health Group Inc had revenues for the full year 2023 of 2.84bn. This was 17.12% above the prior year's results.
Average growth rate+33.10%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.